Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2018-02-16 2018-02-15
Drug Identification Number 02184478 02184478
Brand name CASODEX CASODEX
Common or Proper name bicalutamide bicalutamide
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients BICALUTAMIDE BICALUTAMIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code L02BB L02BB
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-01-04 2018-01-04
Estimated end date 2018-02-16 2018-02-16
Actual end date 2018-02-15 2018-02-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments